LECTURE

Targeted Insights: The Evolution of Biomarkers in Breast Cancer Diagnostics

To access the platform, you must register and log in. Most videos are for Europa Donna members only.

Some areas of the EmpowerED learning platform are reserved for Europa Donna members, including resources and trainings developed specifically for advocates. If you are interested in becoming a member, you can contact us at info@europadonna.org.

Description

Christos Sotiriou of the Jules Bordet Institute highlighted how advances in genomics and biomarkers have transformed breast cancer care, enabling more precise and personalised treatment strategies. He underscored the growing role of next-generation sequencing, liquid biopsies, and immunotherapy in guiding clinical decisions. Looking ahead, he pointed to spatial transcriptomics and artificial intelligence as key drivers of the next era in precision oncology.

Our team

Meet the expert

Christos Sotiriou

Currently the Research Director at the “Fonds de la Recherche Scientifique” (FNRS), a full Professor at the oncology department of Jules Bordet Institute, where he was recently appointed as Director of the Bordet Cancer Research Laboratories.